1) poly (lactide-co-glycolide) microsphere
聚乳酸-羟基乙酸微球
1.
Objective: To investigate the effects of sodium phenytoin poly (lactide-co-glycolide) microspheres Poloxamer 407 gel (PHT-PLGA-MG) on periodontal wound healing in fenestration defects of rats, and provide an in vivo basis for the development of new PHT formulation for local drug delivery.
目的:探讨苯妥英钠聚乳酸-羟基乙酸微球泊洛沙姆407凝胶(sodiumphenytoin poly(lactide-co-glycolide)microspheres poloxamer 407 gel,PHT-PLGA-MG)对大鼠下颌磨牙区颊侧牙周骨开窗缺损牙周再生的影响,为开发苯妥英钠局部用药新剂型提供体内动物实验的依据。
2) poly(DL-lactic-co-glycolic acid)
聚乳酸-羟乙酸微球
4) poly(lactic-co-glycolic acid)
聚乳酸-羟基乙酸
1.
Aim To produce poly(lactic-co-glycolic acid) (PLGA) microspheres, containing a staphylokinase variant (K35R, DGR) with reduced immunogenecity and antiplatelet aggregation activities, which allowed the preservation of protein stability during both particle processing and drug release.
目的制备葡激酶突变体(K35R,DGR)的聚乳酸-羟基乙酸(PLGA)微球,使其在包封和释放过程中都能保持活性。
2.
Objective:To prepare rh-endostatin loaded poly(lactic-co-glycolic acid)(PLGA)microspheres and to evaluate their release behavior in vitro.
目的:制备重组人血管内皮抑制素(rh-endostatin,rh-Endo)的聚乳酸-羟基乙酸[poly(lactic-co-glycolic acid),PLGA]微球,并对微球的体外释放特性进行考察。
5) PLGA
聚乳酸-羟基乙酸
1.
[Objective]To explore the treatment effect of sustained-release BCNU-PLGA microspheres on rat C6 glioma.
以自制聚乳酸-羟基乙酸共聚物微球(BCNU loaded PLGA Microspheres,BCNU-PLGA-MS)制备释放不同时间(4h、1d、2d、3d、7d、14d、21d)的浸提液,体外培养大鼠C6胶质瘤细胞,以不同时间点的浸提液作用于体外培养的细胞,ELISA法检测浸提液对体外培养的大鼠C6胶质瘤细胞MMP-9、b-FGF蛋白表达的影响。
补充资料：可降解淀粉微球和生物降解白蛋白微球阻滞法
可降解淀粉微球和生物降解白蛋白微球阻滞法
介入放射学技术。介入性局部化疗之前，把二者注入靶动脉，可暂时减少动脉血流，再行化疗药物灌注，以减少血液冲刷，保持局部化疗药物浓度的技术。与其他中期和长期栓塞微球不同，DSM和BAM仅造成数十分钟的血流量减少，待其被降解后血流可恢复至以前水平。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条